Found 34 matching trials
Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer. PHASE2 This was a randomized, double-blind, placebo-controlled study conducted in ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study of INCB123667 in Subjects With Advanced Solid Tumors PHASE1 This is an open-label, dose-escalation and dose-expansion study to determin...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer PHASE1 The primary objective of Phase 1b will be to evaluate the safety and tolera...
Show More Location
Holy Cross Health Fort Lauderdale - Holy Cross Hospital
Learn More & Join Trial
Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer PHASE1 Dose Escalation part of the study: To estimate the MTD(s) and/ or RP2D of L...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1) PHASE2 This is a multi-center, open-label Phase II randomized pre-surgical pharmac...
Show More Location
Highlands Oncology Group SC
Learn More & Join Trial
Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole PHASE2 Patients with locally advanced (stage III) breast cancer (LABC) are charact...
Show More Location
Akershus University Hospital
Learn More & Join Trial
Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma PHASE2 The primary purpose of this study is to evaluate the efficacy of LXH254 com...
Show More Status
Active Not Recruiting
Location
The Angeles Clinic and Research Institute
Learn More & Join Trial
Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy PHASE2 This is a Phase II, two-arm, single center, patient preference study design...
Show More Learn More & Join Trial
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials PHASE4 The purpose of this clinical trial (called the FLOTILLA study) is to give c...
Show More Location
St. Joseph's Hospital and Medical Center
Learn More & Join Trial
Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant PHASE3 The purpose of this clinical trial is to study of the molecular features of...
Show More Location
Novartis Investigative Site
Learn More & Join Trial